HYPOVENTILATION IN PATIENTS WITH NORMAL LUNGS. MANAGEMENT OF DRUG POISONING, TETANUS, AND MYASTHENIA GRAVIS.
D000931:Antidotes; D001463:Barbiturates / Q000633:toxicity*; D002800:Cholinesterase Inhibitors; D005984:Glutethimide; D006801:Humans; D007040:Hypoventilation; D008620:Meprobamate; D009020:Morphine; D009157:Myasthenia Gravis; D011041:Poisoning; D001261:Pulmonary Atelectasis; D011654:Pulmonary Edema; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency; D012459:Salicylates; D013742:Tetanus; D013812:Therapeutics; D014116:Toxicology; D014140:Tracheotomy
D000931:Antidotes; D001463:Barbiturates; D002800:Cholinesterase Inhibitors; D012459:Salicylates; D009020:Morphine; D008620:Meprobamate; D005984:Glutethimide; C032232:barbituric acid
ANTIDOTES; ATELECTASIS; BARBITURATE TOXICOLOGY; CHOLINESTERASE INHIBITORS; GLUTETHIMIDE; MEPROBAMATE; MORPHINE; MYASTHENIA GRAVIS; POISONING; PULMONARY EDEMA; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; SALICYLATES; TETANUS; THERAPEUTICS; TOXICOLOGIC REPORT; TRACHEOTOMY